Not every patient responds to the first GLP-1 medication they try
Individual results vary based on starting weight, adherence, diet quality, physical activity, and metabolic factors
Research presented at the ACR Convergence 2025 conference showed that RA patients with elevated BMI who took GLP-1 receptor agonists experienced superior improvements in disease activity scores, pain levels, and weight loss compared to controls
Buyer Takeaway - On the three-entity structure: Understanding that FeelGood (platform), OpenLoop Healthcare Partners PC (medical group), and a compounding pharmacy (medication) are three separate entities matters when you have a complaint or question
Naltrexone blocks alcohol's buzz in your brain, and most doctors still don't prescribe it